MX2012012303A

Plant disease control composition and its use.

Abstract

A composition comprising a carboxamide compound represented by following formula (I), wherein R1 represents a hydrogen atom or a methyl group, and R2 represents a methyl group, a difluoromethyl group or a trifluoromethyl group, and one or more azole compounds selected from group (A) consisting of propiconazole, prothioconazole, triadimenol, prochloraz, penconazole, tebuconazole, flusilazole, diniconazole, bromuconazole, epoxiconazole, difenoconazole, cyproconazole, metconazole, triflumizole, tetraconazole, myclobutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, bitertanol, imazalil, ipconazole, simeconazole, hymexazol, etridiazole and flutriafol.

Term

4.6 yearsleft in the term

Expires 25 April 2031.

5 claims: 2 independent, 3 dependent

1
REIVINDICACIONES Habiéndose descrito la invención como antecede, se reclama como propiedad lo contenido en las siguientes reivindicaciones:1. Una composición para el control de enfermedades vegetales caracterizada porque comprende un compuesto de carboxamida representado por la fórmula (I): (I) bromuconazol, metconazol, fenbuconazol, en donde R 1 representa un átomo de hidrógeno o un grupo metilo, y R 2 representa un grupo metilo, un grupo difluorometilo o un grupo trifluorometilo y uno o varios compuestos de azol seleccionados del grupo (A) que consiste en propiconazol, protioconazol, triadimenol, procloraz, penconazol, tebuconazol, flusilazol, diniconazol, difenoconazol, tetraconazol, fluquinconazol, bitertanol, imazalilo, ipconazol, simeconazol, himexazol, etridiazol y flutriafol.
2
La composición para el control de enfermedades epoxiconazol, triflumizol, hexaconazol, ciproconazol, miclobutanilo, triticonazol, vegetales de conformidad con la reivindicación 1, caracterizada porque la relación en peso del compuesto de carboxamida al (los) compuesto (s) es de 0.1/1 a 10/1 del compuesto de carboxamida / al (los) compuesto(s) de azol.
3
Un método para el control de una enfermedad vegetal caracterizado porque comprende una etapa de tratamiento de una planta o el suelo donde crece una planta con una cantidad efectiva de un compuesto de carboxamida representado por la fórmula (I) :metconazol, triflumizol, fenbuconazol, hexaconazol, en donde R 1 representa un átomo de hidrógeno o un grupo metilo, y R 2 representa un grupo metilo, un grupo difluorometiio o un grupo trifluorometiio y uno o varios compuestos de azol seleccionados del grupo (A) que consiste en propiconazol, protioconazol, triadimenol, procloraz, penconazol, tebuconazol, flusilazol, diniconazol, bromuconazol, epoxiconazol, difenoconazol, ciproconazol, tetraconazol, fluquinconazol, miclobutanilo, triticonazol, bitertanol, imazalilo, ipconazol, simeconazol, himexazol, etridiazol y flutriafol.
4
El método para el control de una enfermedad vegetal de conformidad con la reivindicación 3, caracterizado porque relación en peso del compuesto de carboxamida al (los) compuesto (s) es de 0.1/1 a 10/1 del compuesto de carboxamida / al (los) compuesto(s) de azol.
5
El método para el control de una enfermedad vegetal de conformidad con la reivindicación 3 ó 4, caracterizado porque la planta o el suelo donde crece una planta es poroto de soja o el suelo donde crece el poroto de soja, respectivamente. flutriafol.

Independent claims5

683 paragraphs in 4 sections, as filed

(54) Title: COMPOSITION FOR THE CONTROL OF PLANT DISEASES AND THEIR USE. (54) Title: Plant disease control composition and its use.

(57) Summary

A composition comprising a carboxamide compound represented by formula (I) wherein R1 represents a hydrogen atom or a methyl group, and R2 represents a methyl group, a difluoromethyl group or a trifluoromethyl group and one or more selected azole compounds from group (A) consisting of propiconazole, protioconazole, triadimenol, prochloraz, penconazole, tebuconazole, flusilazole, diniconazole, bromuconazole, epoxiconazole, diphenozole, cyproconazole, metconazole, triflumizole, tetraconazole, miclobutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, bitertanol, imazalil, ipconazole, simeconazole, himexazole, etridiazole, and flutriafol.

(57) Abstract

A composition comprising a carboxamide compound represented by following formula (I), where R1 represents a hydrogen atom or a methyl group, and R2 represents a methyl group, a difluoromethyl group or a trifluoromethyl group, and one or more azole compounds selected from group ( A) consisting of propiconazole, prothioconazole, triadimenol, prochloraz, penconazole, tebuconazole, flusilazole, diniconazole, bromuconazole, epoxiconazole, diphenoconazole, cyproconazole, metconazole, triflumizole, tetraconazole, myclobutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, bitertanol, imazalil, ipconazole, simeconazole, hymexazol, etridiazole and flutriafol.

COMPOSITION FOR THE CONTROL OF VEGETABLE DISEASES AND THEIR

USE

Field of the Invention

The present invention relates to a composition for the control of plant diseases and its use.

Background of the Invention

Many compounds were developed to control plant diseases and are currently in use (see, for example, PTL 1 and 2).

Appointment List

Patent literature

PTL 1: WO 86/02641

PTL 2: WO 92/12970

Brief Description of the Invention

Technical problem

An object of the present invention is to provide a composition with an excellent effect for controlling plant diseases.

Solution to the problem

The inventor of the present invention studied to find a composition with an excellent effect for plant diseases and found that a composition comprising a carboxamide compound represented by the following formula (I) and one or more azole compounds

Ref. 235790 selected from the following group (A) has an excellent effect for controlling plant diseases and then completed the present invention.

The present invention provides the following points

1) to 5).

<td>Moon</td><td>composition</td><td>for</td><td>the control</td><td>of</td><td>diseases</td>

<td>vegetables that</td><td>understands</td><td>a</td><td>compound</td><td>of</td><td>carboxamide</td>

<td>represented by</td><td>the formula</td><td>(D:</td><td></td><td></td><td></td>

methyl, and

where

R1 represents a hydrogen atom or a group

Rz represents a methyl group, a difluoromethyl group or a trifluoromethyl group, and one or more azole compounds selected from group (A) consisting of propiconazole, protioconazole, triadimenol, prochloraz, penconazole, tebuconazole, flusilazole, diniconazole, cyproconazole, miclobutanil, bromuconazole , metconazole, epoxiconazole, triflumizole, fenbuconazole, hexaconazole, diphenoconazole, tetraconazole, fluquinconazole, triticonazole, bitertanol, imazalil, ipconazole, simeconazole, himexazole, etridiazole and flutriafol.

2) The composition for the control of plant diseases according to item [1] above, where the weight ratio of the carboxamide compound to the compound (s) is 0.1 / 1 to 10/1 of the compound of carboxamide / azole compound (s).

3) A method of controlling a plant disease comprising a step of treating a plant or the soil where a plant grows with an effective amount of a carboxamide compound represented by formula (I):

(I) h3c where

R1 represents a hydrogen atom or a methyl group, and

R2 represents a methyl group, a difluoromethyl group or a trifluoromethyl group, and one or more azole compounds selected from group (A) consisting of propiconazole, protioconazole, triadimenol, prochloraz, penconazole, tebuconazole, flusilazole, diniconazole, bromuconazole, epoxiconazole, diphenoconazole , cyproconazole, metconazole, triflumizole, miclobutanil, fenbuconazole, hexaconazole, tetraconazole, fluquinconazole, triticonazole, bitertanol, imazalil, ipconazole, simeconazole, himexazole, etridiazole and flutriafol.

4) The method of controlling a plant disease according to item 3) above, wherein the weight ratio of the carboxamide compound to the compound (s) is Ol / l to 10/1 of the carboxamide compound / to the azole compound (s).

5) The method of controlling a plant disease according to point 3) or 4) above, where the plant or the soil where a plant grows is soy bean or the soil where soy bean grows, respectively.

Advantageous effect of the invention

In accordance with the present invention, various plant diseases can be controlled.

Detailed description of the invention

The composition for the control of plant diseases of the present invention (hereinafter referred to as composition) comprises a carboxamide compound represented by formula (I):

where R1 and R2 they represent the same meanings defined above (hereinafter referred to as carboxamide compound), and one or more azole compounds selected from group (A) consisting of propiconazole, protioconazole, triadimenol, prochloraz, penconazole, tebuconazole, flusilazole, diniconazole , bromuconazole, epoxiconazole, diphenoconazole, cyproconazole, metconazole, triflumizole, tetraconazole, miclobutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, bitertanol, imazalil, ipconazole, simeconazole, himexazole, etridiazole and flutriafol (hereinafter referred to as azole compound).

Carboxamide compounds are those described, for example, in WO 86/02641 or WO 92/12970 and can be prepared by the method described herein.

Particular examples of the carboxamide compounds are as follows:

carboxamide compound represented by formula (1):

(hereinafter referred to as carboxamide compound (1));

carboxamide compound represented by formula (2):

(2) carboxamide (2));

carboxamide compound represented by formula (3):

(hereinafter referred to as carboxamide compound (3)):

carboxamide compound represented by formula (4):

(hereinafter referred to as carboxamide compound (4));

carboxamide compound represented by formula (5):

(hereinafter referred to as carboxamide compound (5)).

Azole compounds are known compounds and are described, for example, in THE PESTICIDE MANUAL - 14to EDITION (published by BCPC) ISBN 1901396142.

These compounds can be obtained from commercially available azole containing products or can be synthesized by generally known methods.

The weight ratio of the carboxamide compound to the azole compounds in the composition is usually 0.01 / 1 to 500/1, and preferably 0.1 / 1 to 10/1 of the carboxamide compound / to the compound (s) ( s) of azole.

Although the composition may itself be a mixture of a carboxamide compound and azole compounds, the composition is usually prepared by mixing a carboxamide compound, azole compounds, and an inert carrier and, if necessary, adding a surfactant and / or other formulation aid and formulating the mixture into an oily formulation, emulsifying concentrate, fluid formulation, wettable powder, water dispersible granules, powder, granules, or the like.

The formulation, which is alone or by addition of another inert component, can be used as a pesticide.

The total content of a carboxamide compound and azole compounds in a composition is usually 0.1 to 99% by weight, preferably 0.2 to 90% by weight and more preferably 1 to 80% by weight.

Examples of the solid carriers used for the formulation include fine powder or granules, for example, of mineral materials such as kaolin clay, attapulgite, bentonite, montmorillonite, acid clay, pyrophyllite, talc, diatomaceous earth and calcite; natural organic materials such as cob powder and walnut powder; synthetic organic materials such as urea; you go out

<td>such as carbonate</td><td>potassium</td><td>and sulfate</td><td>of</td><td>ammonium;</td>

<td>inorganic materials</td><td>synthetic</td><td>like rust</td><td>of</td><td>silicon</td>

<td>synthetic hydrated.</td><td></td><td></td><td></td><td></td>

<td>The examples</td><td colspan="3">of liquid carriers</td><td>include</td>

aromatic hydrocarbons such as xylene, alkylbenzene, and methylnaphthane, · alcohols such as 2-propanol, ethylene glycol, propylene glycol, and ethylene glycol monoethyl ether;

ketones such as acetone, cyclohexanone, and isophorone;

vegetable oils such as soybean oil, cottonseed oil; aliphatic petroleum hydrocarbons; esters; dimethyl sulfoxide; acetonitrile; Water.

Examples of the surfactants include anionic surfactants such as alkylsulfate ester salts, alkylarylsulfonate salts, dialkylsulfosuccinate salts, polyoxyethylenealkylaryl etherphosphoric acid ester salts, ligninsulfonate and polycondensates of naphthalenesulfonate and ionics such as formaldehyde;

non-polyoxyethylenealkylaryl ether surfactants, polyoxyethylene-alkylpolyoxypropylene block copolymers and sorbitan fatty acid esters; and cationic surfactants such as alkyltrimethylammonium salts.

Examples of the other formulation aids include water soluble polymers such as polyvinyl alcohol and polyvinylpyrrolidone; polysaccharides such as gum arabic, alginic acid and its salt, CMC (carboxymethyl cellulose) and xanthan gum; inorganic materials such as magnesium aluminum silicate, alumina sol; preservatives; coloring agents; and stabilizers such as PAP (isopropyl acid phosphate), BHT.

The composition can also be prepared by formulating a carboxamide compound and azole compounds according to the method as described above, then mixing the formulations or their diluents.

The composition can be used to protect a plant from plant disease.

Examples of plant diseases that can be controlled by the composition include the following.

Rice diseases: Magnaporthe grisea, Cochliobolus miyabeanus, Rhizoctonia solani, Gibberella fuj ikuroi;

Wheat diseases: Erysiphe graminis, Fusarium graminearum, F. avenaceum, F. culmorum, Microdochium nivale, Puccinia striiformis, P. graminis, P. recóndita, Micronectriella nivale, Typhula sp., Ustilago tritici, Tilletia caries, Pseudocercosporella hercostarella , Stagonospora nodorum, Pyrenophora tritici-repentis;

Barley diseases: Erysiphe graminis, Fusarium graminearum, F. avenaceum, F. culmorum, Microdochium nivale, Puccinia striiformis, P. graminis, P. hordei, Ustilago nuda, Rhynchosporium secalis, Pyrenophora teres, Cochliobolus sativus, Pyrenophora gram ;

Maize diseases: Ustilago mayáis, Cochliobolus heterostrophus, Gloeocercospora sorghi, Puccinia polysora, Cercospora zeae-maydis, Rhizoctonia solani;

Citrus diseases: Diaporthe citri, Elsinoe fawcetti, Penicillium digitatum, P. italicum, parasitic Phytophthora, Phytophthora citrophthora;

Apple diseases: Monilinia mali, Valsa ceratosperma, Podosphaera leucotricha, apple pathotype Alternaría alternata, Venturia inaequalis, Colletotrichum acutatum, Phytophtora cactorum;

Pear diseases: Venturia nashicola, V. pirina, Japanese pear patotipi Alternaría alternata, Gymnosporangium haraeanum, Phytophtora cactorum;

Peach diseases: Monilinia fructicola, Cladosporium carpophilum, Phomopsis sp .;

Grape diseases: Elsinoe ampelina,

Glomerella cingulata, Uninula necator, Phakopsora ampelopsidis, Guignardia bidwellii, Plasmopara viticola;

Persimmon diseases: Gloesporium kaki,

Cercospora kaki, Mycosphaerela nawae;

Pumpkin diseases: Colletotrichum lagenarium, Sphaerotheca fuliginea, Mycosphaerella melonis, Fusarium oxysporum, Pseudoperonospora cubensis, Phytophthora sp., Pythium sp .;

Tomato diseases: Alternaría solani,

Cladosporium fulvum, Phytophthora infestans;

Eggplant diseases: Phomopsis vexans,

Erysiphe cichoracearum;

Plant diseases Brassicaceous: Alternate japanica, Cercosporella brassicae, Plasmodiophora brassicae, Peronospora parasitica;

Welsh onion diseases: Puccinia allii, Peronospora destructor;

Soy bean diseases: Cercospora kikuchii, Elsinoe glycines, Diaporthe phaseolorum var. sojae, Septoria glycines, Cercospora sojina, Phakopsora pachyrhizi, Phytophthora sojae, Rhizoctonia solani, Corynespora almosticola, Sclerotinia sclerotiorum;

Bean diseases: Colletrichum lindemthianum;

Peanut diseases: Cercospora personata,

Cercospora arachidicola, Sclerotium rolfsii;

Pea diseases: Erysiphe pisi;

Potato diseases: Alternaría solarii,

Phytophthora infestans, Phytophthora erythroseptica, Spongospora subterranean, f. sp. Subterranean;

Strawberry diseases: Sphaerotheca humuli, Glomerella cingulata;

Tea diseases: Exobasidium reticulatum,

Elsinoe leucospila, Pestalotiopsis sp., Colletotrichum theaesinensis;

Tobacco diseases; I would alternate longipes,

Erysiphe cichoracearum, Colletotrichum tabacum, Peronospora tabacina, Phytophthora nicotianae;

Rapeseed diseases: Sclerotinia sclerotiorum,

Rhizoctonia solani;

Cotton diseases: Rhizoctonia solani;

Beet diseases: Cercospora beticola, Thanatephorus cucumeris, Thanatephorus cucumeris, Aphanomyces cochlioides;

Rose diseases: Diplocarpon rosae,

Sphaerotheca pannosa, Peronospora sparsa;

Chrysanthemum and asteraceae diseases: Bremia lactuca, Septoria chrysanthemi-indici, Puccinia horiana;

Diseases of various plants: Pythium aphanidermatum, Pythium debarianum, Pythium graminicola, Pythium irregularulare, Pythium ultimum, Botrytis cinérea, Sclerotinia sclerotiorum;

Radish diseases: Alternaría brassicicola;

Zoysia diseases: Sclerotinia homeocarpa, Rhizoctonia solani;

Banana diseases: Mycosphaerella fijiensis, Mycosphaerella musicola;

Sunflower diseases: Plasmopara halstedii;

Seed diseases or diseases in the initial growth stage of various plants caused by Aspergillus spp., Penicillium spp., Fusarium spp.,

Gibberella spp., Tricoderma spp., Thielaviopsis spp., Rhizopus spp., Mucor spp., Corticium spp., Rhoma spp., Rhizoctonia spp., Diplodia spp., Or the like;

Viral diseases of various plants mediated by Polymixa spp., Olpidium spp. or the like.

Examples of plants for which the composition can be used are as follows:

Agricultural crops: corn, rice, wheat, barley, rye, oats, sorghum, cotton, soybeans, peanuts, buck wheat, beets, rapeseed, sunflower, sugar cane, tobacco plant, and the like;

Vegetables: nightshade vegetables (eggplant, tomato, bell pepper, chili, potato, etc.), cucurbit vegetables (cucumber, squash, zucchini, watermelon, melon, etc.); cruciferous vegetables (radish, white turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, leaf mustard, broccoli, cauliflower, etc.), asteraceae vegetables (burdock, Garland chrysanthemum, artichoke, lettuce, etc.), liliaceous vegetables ( green onion, onion, garlic, asparagus, etc.), umbelliferous vegetables (carrots, parsley, celery, parsnip, etc.), chenopodia vegetables (spinach, thistle, etc.), lamiaceous vegetables (Japanese perilla, mint, basil, etc.), strawberry, sweet potato, yam, taro, and the like;

Flower plants;

Ornamental foliage plants?

Grass;

Fruit trees: pome fruits (apple, common pear, Japanese pear, Chinese quince, quince, etc.), stone fruits (peach, plum, nectarine, Japanese plum, cherry, apricot, prune, etc.), citrus fruits (tangerine, orange , lemon, lime, grapefruit, etc.), walnuts (chestnuts, walnuts, hazelnuts, almonds, pistachios, cashews, macadamia nuts, etc.), berries (cassis, blueberries, blackberries, raspberries, etc.), grape , persimmon, olive, Japanese plum, banana, coffee, date, coconut palm, and the like;

trees other than fruit trees: tea, mulberry, flowering trees, road trees (ash, birch, American dogwood, eucalyptus, ginkgo, lilac, holly, willow, oak, cercis, sweetgum, banana, zelkova, Japanese arborvitae, spruce, Japanese hemlock, needle juniper, pine, spruce, yew), and the like.

The plants described above may be those that have resistance imparted by a genetic engineering technique.

Among the above plants, the composition is expected to have an excellent effect for control in particular on plant diseases caused by soy.

Among the above plant diseases, soy diseases on which an especially excellent effect of the composition is expected are Rhizoctonia solani, Cercospora kikuchii, Septoria glycines, Corynespora almosticola, Phakopsora pachyrizi, Sclerotinia sclerotiorum, Cercospora sojina and the like.

<td>The</td><td>following</td><td>compositions exemplify</td><td>a</td>

<td>modality of the</td><td>composition</td><td>OR ·</td><td></td>

<td>a</td><td>composition</td><td>which comprises compound</td><td>of</td>

<td>carboxamide (1)</td><td colspan="2"> and propiconazole;</td><td></td>

<td>a</td><td>composition</td><td>which comprises compound</td><td>of</td>

carboxamide (1) and protioconazole;

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td colspan="2"> and triadimenol;</td><td></td><td></td><td></td>

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and prochloraz;</td><td></td><td></td><td></td><td></td>

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (1) and tebuconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and flusilazol;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and diniconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and bromuconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (1) and epoxiconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and diphenoconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and cyproconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and metconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (1) and tetraconazole;

<td>a</td><td>composition comprising</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and fluquinconazole;</td><td></td><td></td>

<td>a</td><td>composition comprising</td><td>compound</td><td>of</td>

<td>carboxamide (1)</td><td> and triticonazole;</td><td></td><td></td>

<td>a</td><td>composition comprising</td><td>compound</td><td>of</td>

carboxamide (1) and ipconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td> and propiconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td> and protioconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td> and triadimenol;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (2) and prochloraz;

composition comprising carboxamide compound (2) and tebuconazole;

a composition comprising carboxamide compound (2) and flusilazole;

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td colspan="2"> and diniconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td colspan="2"> and bromuconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (2) and epoxiconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td> and diphenoconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td> and cyproconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td> and metconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (2) and tetraconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td> and fluquinconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2)</td><td> and triticonazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (2) and ipconazole;

<td>a carboxamide (3)</td><td colspan="2">composition that and propiconazole;</td><td>understands</td><td>compound</td><td>of</td>

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (3) and protioconazole;

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (3)</td><td colspan="2"> and triadimenol;</td><td></td><td></td><td></td>

<td>a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (3)</td><td> and prochloraz;</td><td></td><td></td><td></td><td></td>

<td>5 a</td><td>composition</td><td>than</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (3) and tebuconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (3)</td><td> and flusilazol;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>10 carboxamide (3)</td><td> and diniconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (3) and bromuconazole;

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (3)</td><td> and epoxiconazole;</td><td></td><td></td><td></td>

<td> 15</td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (3)</td><td> and diphenoconazole;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (3)</td><td> and cyproconazole;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td> 20</td><td>carboxamide (3)</td><td> and metconazole;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (3)</td><td> and tetraconazole;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (3)</td><td> and fluquinconazole;</td><td></td><td></td><td></td>

<td> 25</td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (3)</td><td> and triticonazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (3)</td><td> and ipconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (4) and propiconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and protioconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and triadimenol;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (4) and prochloraz;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and tebuconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and flusilazol;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (4) and diniconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and bromuconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and epoxiconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and diphenoconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (4) and cyproconazole;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and metconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and tetraconazole;</td><td></td><td></td><td></td>

<td>5 a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and fluquinconazole;</td><td></td><td></td><td></td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (4) and triticonazole;

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td> 10</td><td>carboxamide (4)</td><td> and ipconazole;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (5)</td><td> and propiconazole;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (5)</td><td> and protioconazole;</td><td></td><td></td><td></td>

<td> 15</td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (5) and triadimenol;

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (5)</td><td> and prochloraz;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td> 20</td><td>carboxamide (5)</td><td> and tebuconazole;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (5)</td><td> and flusilazol;</td><td></td><td></td><td></td>

<td></td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td></td><td>carboxamide (5)</td><td> and diniconazole;</td><td></td><td></td><td></td>

<td> 25</td><td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (5) and bromuconazole;

a composition that carboxamide (5) and epoxiconazole;

a composition that carboxamide (5) and diphenoconazole;

a composition that carboxamide (5) and cyproconazole;

a composition that carboxamide (5) and metconazole;

a composition that carboxamide (5) and tetraconazole;

a composition that carboxamide (5) and fluquinconazole;

a composition that carboxamide (5) and triticonazole;

a composition that carboxamide (5) and ipconazole;

a composition that carboxamide (1) and propiconazole, weight of carboxamide compound 0.1 / 1 to 10/1;

a composition that carboxamide (1) and protioconazole, weight of carboxamide compound 0.1 / 1 to 10/1;

comprises comprises comprises comprises comprises comprises comprises compound compound compound compound compound compound compound compound comprises compound in which the ratio (1) to propiconazole is comprises compound in which the ratio (1) to protioconazole is from from from from from from of in of in of of a composition comprising carboxamide compound (1) and triadimenol, wherein the weight ratio of carboxamide compound (1) to triadimenol is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and prochloraz, in which the weight ratio of carboxamide compound (1) to prochloraz is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and tebuconazole, in which the weight ratio of carboxamide compound (1) to tebuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and flusilazole, in which the weight ratio of carboxamide compound (1) to flusilazole is 0.1 / 1 to 10/1 ;.

a composition comprising carboxamide compound (1) and diniconazole, in which the weight ratio of carboxamide compound (1) to diniconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and bromuconazole, in which the weight ratio of carboxamide compound (1) to bromuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and epoxiconazole, in which the weight ratio of carboxamide compound (1) to epoxiconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and diphenoconazole, in which the weight ratio of carboxamide compound (1) to diphenoconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and cyproconazole, in which the weight ratio of carboxamide compound (1) to cyproconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and metconazole, in which the weight ratio of carboxamide compound (1) to metconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and tetraconazole, in which the weight ratio of carboxamide compound (1) to tetraconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and fluquinconazole, in which the weight ratio of carboxamide compound (1) to fluquinconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and triticonazole, in which the weight ratio of carboxamide compound (1) to triticonazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (1) and ipconazole, in which the weight ratio of carboxamide compound (1) to ipconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and propiconazole, in which the weight ratio of carboxamide compound (2) to propiconazole is

0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and protioconazole, in which the weight ratio of carboxamide compound (2) to protioconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and triadimenol, in which the weight ratio of carboxamide compound (2) to triadimenol is Ol / l to 10/1;

a composition comprising carboxamide compound (2) and prochloraz, in which the weight ratio of carboxamide compound (2) to prochloraz is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and tebuconazole, in which the weight ratio of carboxamide compound (2) to tebuconazole is 0.1 / 1 to

10/1;

a composition comprising carboxamide compound (2) and flusilazole, in which the weight ratio of carboxamide compound (2) to flusilazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and diniconazole, in which the weight ratio of · carboxamide compound (2) to diniconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and bromuconazole, in which the weight ratio of carboxamide compound (2) to bromuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and epoxiconazole, in which the weight ratio of carboxamide compound (2) to epoxiconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and diphenoconazole, in which the weight ratio of carboxamide compound (2) to diphenoconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and cyproconazole, in which the weight ratio of carboxamide compound (2) to cyproconazole is

0.1 / 1 to 10/1;

a composition comprising carboxamide compound (2) and metconazole, in which the weight ratio of carboxamide compound (2) to metconazole is 0.1 / 1 to 10/1;

<td>a composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2) and tetraconazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td>carboxamide compound weight</td><td colspan="2">(2) a tetraconazole is</td><td>of</td>

<td>a composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2) and fluquinconazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td>carboxamide compound weight</td><td colspan="2">(2) a fluquinconazole is</td><td>of</td>

<td>a composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (2) and triticonazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td>carboxamide compound weight</td><td colspan="2">(2) a triticonazole is</td><td>of</td>

<td>a composition that</td><td>understands</td><td>compound</td><td>of</td>

carboxamide (2) and ipconazole, in which the weight ratio of carboxamide compound (2) to ipconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and propiconazole, in which the weight ratio of carboxamide compound (3) to propiconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and protioconazole, in which the weight ratio of carboxamide compound (3) to protioconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and triadimenol, in which the weight ratio of carboxamide compound (3) to triadimenol is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and prochloraz, in which the weight ratio of carboxamide compound (3) to prochloraz is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and tebuconazole, in which the weight ratio of carboxamide compound (3) to tebuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and flusilazole, in which the weight ratio of carboxamide compound (3) to flusilazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and diniconazole, in which the weight ratio of carboxamide compound (3) to diniconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and bromuconazole, in which the weight ratio of carboxamide compound (3) to bromuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and epoxiconazole, in which the weight ratio of carboxamide compound (3) to epoxiconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and diphenoconazole, in which the weight ratio of carboxamide compound (3) to diphenoconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and cyproconazole, in which the weight ratio of carboxamide compound (3) to cyproconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and metconazole, in which the weight ratio of carboxamide compound (3) to metconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and tetraconazole, in which the weight ratio of carboxamide compound (3) to tetraconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and fluquinconazole, in which the weight ratio of carboxamide compound (3) to fluquinconazole is

0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and triticonazole, in which the weight ratio of carboxamide compound (3) to triticonazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (3) and ipconazole, in which the weight ratio of carboxamide compound (3) to ipconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and propiconazole, in which the weight ratio of carboxamide compound (4) to propiconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and protioconazole, in which the weight ratio of carboxamide compound (4) to protioconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and triadimenol, in which the weight ratio of carboxamide compound (4) to triadimenol is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and prochloraz, in which the weight ratio of carboxamide compound (4) to prochloraz is 0.1 / 1 to

10/1;

a composition comprising carboxamide compound (4) and tebuconazole, in which the weight ratio of carboxamide compound (4) to tebuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and flusilazole, in which the weight ratio of carboxamide compound (4) to flusilazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and diniconazole, in which the weight ratio of carboxamide compound (4) to diniconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and bromuconazole, in which the weight ratio of carboxamide compound (4) to bromuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and epoxiconazole, in which the weight ratio of carboxamide compound (4) to epoxiconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and diphenoconazole, in which the weight ratio of carboxamide compound (4) to diphenoconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (4) and cyproconazole, in which the weight ratio of carboxamide compound (4) to cyproconazole is 0.1 / 1 to 10/1;

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and metconazole, in</td><td colspan="3">which the weight ratio</td>

<td colspan="2">carboxamide compound (4)</td><td colspan="2">to metconazole is 0.1 / 1</td><td>to</td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and tetraconazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td colspan="2">carboxamide compound weight</td><td colspan="2">(4) a tetraconazole is</td><td>of</td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and fluquinconazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td colspan="2">carboxamide compound weight</td><td colspan="2">(4) a fluquinconazole is</td><td>of</td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and triticonazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td colspan="2">carboxamide compound weight</td><td colspan="2">(4) a triticonazole is</td><td>of</td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (4)</td><td> and ipconazole, in</td><td colspan="3">which the weight ratio</td>

<td colspan="2">carboxamide compound (4)</td><td>to ipconazole</td><td>is 0.1 / 1</td><td>to</td>

<td>a</td><td>composition that</td><td>understands</td><td>compound</td><td>of</td>

<td>carboxamide (5)</td><td> and propiconazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td>carboxamide compound weight</td><td>(5) a propiconazole is</td><td>of</td>

<td>a composition that</td><td>comprises compound</td><td>of</td>

<td>carboxamide (5) and protioconazole,</td><td>in which the relationship</td><td>in</td>

<td>carboxamide compound weight</td><td>(5) a protioconazole is</td><td>of</td>

<td>a composition that</td><td>comprises compound</td><td>of</td>

carboxamide (5) and triadimenol, in which the weight ratio of carboxamide compound (5) to triadimenol is 0.1 / 1 10/1;

A composition comprising carboxamide compound (5) and prochloraz, in which the weight ratio of carboxamide compound (5) to prochloraz is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (5) and tebuconazole, in which the weight ratio of carboxamide compound (5) to tebuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (5) and flusilazole, in which the weight ratio of carboxamide compound (5) to flusilazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (5) and diniconazole, in which the weight ratio of carboxamide compound (5) to diniconazole is 0.1 / 1 to

10/1;

a composition comprising carboxamide compound (5) and bromuconazole, in which the weight ratio of carboxamide compound (5) to bromuconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (5) and epoxiconazole, in which the weight ratio of carboxamide compound (5) to epoxiconazole is 0.1 / 1 tolO / 1;

a composition comprising carboxamide compound (5) and diphenoconazole, in which the weight ratio of carboxamide compound (5) to diphenoconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (5) and cyproconazole, in which the weight ratio of carboxamide compound (5) to cyproconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (5) and metconazole, in which the weight ratio of carboxamide compound (5) to metconazole is 0.1 / 1 to 10/1;

a composition comprising carboxamide compound (5) and tetraconazole, in which the weight ratio of carboxamide compound (5) to tetraconazole is

0.1 / 1 to 10/1;

<td></td><td>a composition that</td><td>understands</td><td>compound</td><td>of</td>

<td colspan="2">carboxamide (5) and fluquinconazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td>weight of</td><td>carboxamide compound</td><td colspan="2">(5) a fluquinconazole is</td><td>of</td>

<td></td><td>a composition that</td><td>understands</td><td>compound</td><td>of</td>

<td colspan="2">carboxamide (5) and triticonazole,</td><td>in which</td><td>the relationship</td><td>in</td>

<td>weight of</td><td>carboxamide compound</td><td colspan="2">(5) a triticonazole is</td><td>of</td>

a composition comprising carboxamide compound (5) and ipconazole, in which the weight ratio of carboxamide compound (5) to ipconazole is 0.1 / 1 to 10/1.

The plant disease control method (hereinafter referred to as the control method) can be carried out by treating a plant or the soil where a plant grows with an effective amount of a carboxamide compound and azole compounds.

The part of the plant to be treated is the stem and leaf of a plant, seed or bulb of a plant, and the bulb involves bulb, corm, rhizome, tuber, tuberous root, and rhizophore.

In the control method, the treatment of a plant or the soil where a plant grows with a carboxamide compound and azole compounds can be carried out separately at the same time, but the treatment is usually carried out using a composition for convenience.

In the control method, treatment with a carboxamide compound and azole compounds is, for example, application on stems and leaves, application on the ground, application on roots or application on seeds.

Examples of the application on stems and leaves include a treatment for the surface of a cultivated plant by spraying stems and leaves or stems and trees.

Examples of root application include a method of immersing the whole plant or the root of a plant in a liquid containing a carboxamide compound and azole compounds and a method of adhesion of a solid preparation comprising a compound of carboxamide, azole compounds and a solid carrier on the root of a plant.

Examples of soil application include a method of spraying a composition onto a soil, a method of mixing a composition with a soil, and a method of irrigation of a composition into the soil.

Examples of application on seeds include a method of treating seeds or bulbs of a plant to protect against a plant disease with a composition. In particular, the application can be carried out by spraying a suspension of a composition to the surface of the seeds or bulbs or by dispersion of wettable powder, emulsifying concentrate or fluid formulation itself or a mixture of them with a small amount of water on the seeds or bulbs or by immersing the seeds in a solution of a composition for a prescribed time, by applying a film coating or an application of pellet coating.

The amount of a carboxamide compound and azole compounds used in the control method is different depending on the type of a plant to be treated, the type of plant disease to be controlled and its frequency, the type of formulation, treatment period, method of treatment, place of treatment, weather condition, and the like.

When a composition is applied to stems and / or leaves of a plant or to the soil where a plant grows, the total amount of a carboxamide compound and azole compounds is usually 1g to 500g / 1000m2, preferably from 2 g to 200 g / 1000 m2 and, more preferably, from 10 g to 100 g / 1000 m2.

When a composition is applied to seeds of a plant, the total amount of a carboxamide compound and azole compounds is usually 0.001 g to 10 g / 1 kg of the seeds and preferably 0.01 gag / 1 kg of the seeds .

An emulsifying concentrate, wettable powder, or fluid formulation is usually by diluting the formulation with water and spraying the diluted formulation. In this case, the concentration of a carboxamide compound and azole compounds in total of the diluted formulation is usually 0.0005 to 2% by weight, and preferably 0.005 to 1% by weight.

The powdery formulation, the granulated formulation and the like can usually be used without dilution.

Examples

The present invention is explained in more detail with Formulation Examples and Test Examples. However, the present invention is not limited to the following examples.

In the following examples, part means part by weight, unless otherwise indicated.

Formulation example 1

One of the carboxamide compounds (1) to (5) (2.5 parts), propiconazole (1.25 parts), polyoxyethylene anesthenylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

polyoxyethylene anesthenylphenyl ether

Formulation example 2

One of the carboxamide compounds (1) to (5) (2.5 parts), protioconazole (1.25 parts), polyoxyethylene anesthenylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation example 3

One of the carboxamide compounds (1) to (5) (2.5 parts), triadimenol (1.25 parts), polyoxyethylene anesthenylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation example 4

One of the carboxamide compounds (1) to (5) (2.5 parts), prochloraz (1.25 parts), polyoxyethylene anesthenylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 5

One of the carboxamide compounds (1) to (5) (2.5 parts), tebuconazole (1.25 parts), (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 6

One of the carboxamide compounds (1) to (5) (2.5 parts), flusilazole (1.25 parts), polyoxyethylene anesthenylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 7

One of the carboxamide compounds (1) to (5) (2.5 parts), diniconazole (1.25 parts), polyoxyethylenesyrylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 8

One of the carboxamide compounds (1) to (5) (2.5 parts), bromuconazole (1.25 parts), polyoxyethylenesyrylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 9

One of the carboxamide compounds (1) to (5) parts, epoxiconazole parts), (1.25 (2.5 (14 polyoxyethylenesyrylphenyl ether) (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 10

One of the carboxamide compounds (1) to (5) (2.5 parts), diphenoconazole (1.25 parts), polyoxyethylenesyrylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 11

One of the carboxamide compounds (1) to (5) (2.5 parts), cyproconazole (1.25 parts), polyoxyethylenesyrylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 12

One of the carboxamide compounds (1) to (5) (2.5 parts), metconazole (1.25 parts), polyoxyethylene anesthenylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 13

One of the carboxamide compounds (1) to (5) (2.5 parts), tetraconazole (1.25 parts), polyoxyethylene anesthenylphenyl ether (14 parts), calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 14

<td></td><td>One of the</td><td>compounds</td><td>of</td><td>carboxamide</td><td>(1) to (5)</td>

<td> (2.5</td><td>parts),</td><td colspan="2">fluquinconazole</td><td> (1.25</td><td>parts),</td>

<td colspan="3">polyoxyethylene anesthenylphenyl ether</td><td></td><td> (14</td><td>parts),</td>

<td colspan="2">dodecylbenzenesulfonate</td><td>calcium</td><td> (6</td><td colspan="2">parts) and xylene (76.25</td>

<td>parts)</td><td>they mix</td><td>well for</td><td colspan="2">give each</td><td>of the</td>

formulations, respectively.

Formulation Example 15

<td rowspan="2"> (2.5</td><td colspan="2">One of the carboxamide compounds</td><td rowspan="2">(1) to (5) parts),</td>

<td>parts), miclobutanil</td><td> (1.25</td>

<td colspan="2">polyoxyethylene anesthenylphenyl ether</td><td> (14</td><td>parts),</td>

Calcium dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 16

One of the carboxamide compounds (1) to (5) (2.5 parts), ipconazole (1.25 parts), parts), polyoxyethylenesyrylphenyl ether (14 dodecylbenzenesulfonate (6 parts) and xylene (76.25 parts) mix well to give each of the formulations, respectively.

Formulation Example 17

One of the carboxamide compounds (1) to (5) (2 parts), propiconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by a wet grinding method to give each of the formulations, respectively.

Formulation Example 18

One of the carboxamide compounds (1) to (5) (2 parts), protioconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by a wet grinding method to give each of the formulations, respectively.

Formulation Example 19

One of the carboxamide compounds (1) to (5) (2 parts), triadimenol (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 20

One of the carboxamide compounds (1) to (5) (2 parts), himexazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 21

One of the carboxamide compounds (1) to (5) (2 parts), tebuconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by a wet grinding method to give each of the formulations, respectively.

Formulation Example 22

One of the carboxamide compounds (1) to (5) (2 parts), flusilazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by a wet grinding method to give each of the formulations, respectively.

Formulation Example 23

One of the carboxamide compounds (1) to (5) (2 parts), diniconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 24

One of the carboxamide compounds (1) to (5) (2 parts), bromuconazole (8 parts), a mixture of white carbon and ammonium salt of polyoxyethylenealkylether sulfate (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 25

One of the carboxamide compounds (1) to (5) (2 parts), epoxiconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 26

One of the carboxamide compounds (1) to (5) (2 parts), diphenoconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 27

One of the carboxamide compounds (1) to (5) (2 parts), cyproconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 28

One of the carboxamide compounds (1) to (5) (2 parts), metconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 29

One of the carboxamide compounds (1) to (5) (2 parts), tetraconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 30

One of the carboxamide compounds (1) to (5) (2 parts), fluquinconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 31

One of the carboxamide compounds (1) to (5) (2 parts), triticonazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 32

One of the carboxamide compounds (1) to (5) (2 parts), ipconazole (8 parts), a mixture of white carbon and polyoxyethylenealkylether sulfate ammonium salt (weight ratio 1: 1) (35 parts) and water ( 55 parts) are mixed and the mixture is crushed by means of a wet grinding method to give each of the formulations, respectively.

Formulation Example 33

One of the carboxamide compounds (1) to (5) (5 parts), propiconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method.

An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation Example 34

One of the carboxamide compounds (1) to (5) (5 parts), protioconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation Example 35

One of the carboxamide compounds (1) to (5) (5 parts), triadimenol (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method.

Formulation Example 36

One of the carboxamide compounds (1) to (5) (5 parts), prochloraz (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method.

Formulation Example 37

One of the carboxamide compounds (1) to (5) (5 parts), tebuconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method.

Formulation Example 38

One of the carboxamide compounds (1) to (5) (5 parts), flusilazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method.

Formulation Example 39

One of the carboxamide compounds (1) to (5) (5 parts), diniconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation Example 40

One of the carboxamide compounds (1) to (5) (5 parts), bromuconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method.

Formulation Example 41

One of the carboxamide compounds (1) to (5) (5 parts), epoxiconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation example 42

One of the carboxamide compounds (1) to (5) (5 parts), diphenoconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation example 43

One of the carboxamide compounds (1) to (5) (5 parts), cyproconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation example 44

One of the carboxamide compounds (1) to (5) (5 parts), metconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by a wet milling method.

Formulation Example 45

One of the carboxamide compounds (1) to (5) (5 parts), tetraconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation Example 46

One of the carboxamide compounds (1) to (5) (5 parts), fluquinconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation Example 47

One of the carboxamide compounds (1) to (5) (5 parts), triticonazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation Example 48

One of the carboxamide compounds (1) to (5) (5 parts), ipconazole (10 parts), sorbitan trioleate (1.5 parts) and an aqueous solution (28.5 parts) containing polyvinyl alcohol (2 parts) are mixed and the mixture is ground by means of a wet milling method. An aqueous solution (45 parts) containing xanthan gum (0.05 parts) and magnesium aluminum silicate (0.1 parts) is added to the comminuted mixture, and then propylene glycol (10 parts) is added to the mixture. The resulting mixture is mixed by stirring to give each of the formulations, respectively.

Formulation Example 49

One of the compounds of carboxamide (1) to (5) (1 part), propiconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 50

One of the compounds of carboxamide (1) to (5) (1 part), protioconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 51

One of the compounds of carboxamide (1) to (5) (1 part), triadimenol (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 52

One of the compounds of carboxamide (1) to (5) (1 part), prochloraz (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 53

One of the compounds of carboxamide (1) to (5) (1 part), tebuconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 54

One of the compounds of carboxamide (1) to (5) (1 part), flusilazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 55

One of the compounds of carboxamide (1) to (5) (1 part), diniconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 56

One of the compounds of carboxamide (1) to (5) (1 part), bromuconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 57

One of the compounds of carboxamide (1) to (5) (1 part), epoxiconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 58

One of the compounds of carboxamide (1) to (5) (1 part), diphenoconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 59

One of the compounds of carboxamide (1) to (5) (1 part), cyproconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 60

One of the compounds of carboxamide (1) to (5) (1 part), metconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 61

One of the compounds of carboxamide (1) to (5) (1 part), tetraconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated and then dried to give each of the formulations,

SO respectively.

Formulation Example 62

One of the compounds of carboxamide (1) to (5) (1 part), fluquinconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 63

One of the compounds of carboxamide (1) to (5) (1 part), triflumizole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 64

One of the compounds of carboxamide (1) to (5) (1 part), ipconazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 65

One of the compounds of carboxamide (1) to (5) (1 part), himexazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 66

One of the compounds of carboxamide (1) to (5) (1 part), etridiazole (4 parts), synthesized hydrated silicon oxide (1 part), calcium ligninsulfonate (2 parts), bentonite (30 parts) and clay of kaolin (62 parts) mix well and crush. Water is added to the mixture and the mixture is kneaded sufficiently, granulated, and then dried to give each of the formulations, respectively.

Formulation Example 67

One of the carboxamide compounds (1) to (5) (12.5 parts), tebuconazole (37.5 parts), calcium ligninsulfonate (3 parts), sodium lauryl sulfate (2 parts) and synthesized hydrated silicon oxide (45 parts) are mixed well and crushed to give each of the formulations, respectively.

Formulation Example 68

One of the carboxamide compounds (1) to (5) (3 parts), protioconazole (2 parts), kaolin clay (85 parts) and talc (10 parts) are mixed well and crushed to give each of the formulations , respectively.

Test Examples using each of the compositions are shown below.

Test example 1

A cyclohexanone solution (100 pl) containing a prescribed amount (weight) of a test compound was applied to soybeans (variety: Natto shoriu) (10g) using a rotary seed treatment apparatus (seed freshener). , manufactured by HansUlrich Hege GmbH).

One day after application, a plastic pot was filled with soil contaminated by Rhizoctonia solani and the seeds treated with the test compound were sown in the soil and grown in a glass greenhouse for 20 days (hereinafter referred to as as treated plot).

After that, the presence of the disease caused by Rhizoctonia solani was observed in the young plants that germinated from each seed and the severity of the disease was calculated according to the following calculation formula (1).

On the other hand, soybeans that were not treated as above were cultivated in the same way as before (hereinafter referred to as untreated plot) and disease severity in the untreated plot was calculated in the same way than the previous treated plot.

Based on the previous pathological severities in the treated plot and the untreated plot, the efficacy in the treated plot was evaluated according to the following calculation formula (2).

The results are shown in Table 1 to Table

Calculation formula (1):

Disease severity (%) = (number of young infected plants / total number of young plants) x 100

Calculation formula (2):

Efficacy (%) = [1 - (disease severity in the treated plot / disease severity in the untreated plot)] x 100

Table 1

<td>Carboxamide compound (one) [g / 100 kg of seeds]</td><td>Triticonazole [g / 100 kg of seeds]</td><td>Effectiveness {%)</td>

Table 2

<td>Carboxamide compound (5) [g / 100 kg of seeds]</td><td>Triticonazole [g / 100 kg of seeds]</td><td>Effectiveness (%)</td>

<td colspan="3">Table 3</td>

<td>Carboxamide compound</td><td>Fluquinconazole</td><td>Effectiveness</td>

<td>[g / 100 kg of seeds]</td><td>seeds]</td><td></td>

Table 4

<td>Carboxamide compound (5) [g / 100 kg of seeds]</td><td>Fluquinconazole [g / 100 kg of seeds]</td><td>Effectiveness (%)</td>

<td colspan="3">Table 5</td>

<td>Carboxamide compound (one) [g / 100 kg of seeds]</td><td>Ipconazole [g / 100 kg of seeds]</td><td>Effectiveness (%)</td>

Table 6

<td>Carboxamide compound (5) [g / 100 kg of seeds]</td><td>Ipconazole [g / 100 kg of seeds]</td><td>Effectiveness (%)</td>

Table 7

<td colspan="2">Carboxamide compound (1)</td><td rowspan="2">Diphenoconazole [g / 100 kg of seeds]</td><td rowspan="2">Effectiveness (%)</td>

<td>[g / 100</td><td>kg of seeds]</td>

Table 8

<td>Compound</td><td>Diphenoconazole</td><td>Efficacy (%)</td>

<td>carboxamide (5)</td><td>[g / 100 kg of</td><td></td>

<td>[g / 100 kg of</td><td>seeds]</td><td></td>

<td>seeds]</td><td></td><td></td>

Test example 2

Soil was placed in a plastic pot and soybeans (variety: Nattoshoriu) were sown in the soil and grown in a greenhouse for 14 days. Test compounds were dissolved in CEC cocktail (cyclohexanone: Solpol ™ 2680X (manufactured by Toho Kagaku Kogyo) = 5: 1 (by volume)) to give an emulsifying concentrate containing a total amount of 5% (w / v) of the test compounds. The emulsifying concentrate was mixed with water to give a prescribed concentration. The mixture was sprayed on the soybean leaves in order to adhere sufficiently. After spraying, the plant was air-dried and, one day later, the plant was inoculated with an aqueous suspension with Phakopsora pachyrhizi urediniospora (approximately 10,000 / ml) by spraying the suspension. After inoculation, the plant was left in a humid environment at 20-23 ° C for one day and then cultivated in a greenhouse for 10 days (hereinafter referred to as the treated plot). Thereafter, Phakopsora pachyrhizi's area of injury was investigated.

On the other hand, soybean was grown in the same way as the previous treated plot, except that the plant was not treated with the mixture containing the test compounds (hereinafter referred to as untreated plot) and the area of Phakopsora pachyrhizi's injury was investigated in the same manner as before.

Based on the previous area of injury in the treated plot and the untreated plot, the effect on the treated plot was evaluated according to the following calculation formula (3).

Calculation formula (3):

Efficacy (%) = [1 - (area of injury in the treated plot / area of injury in the untreated plot)] x 100

The results are shown in the following

Table 7 to Table 14.

Table 9

<td>Compound carboxamide (1) [ppm]</td><td>Cyproconazole [ppm]</td><td>Efficacy (%)</td>

<td colspan="3">Table 10</td>

<td>Compound</td><td>Cyproconazole</td><td>Efficacy (%)</td>

<td>carboxamide (5)</td><td>[ppm]</td><td></td>

Table 11

<td>Compound carboxamide (1) [ppm]</td><td>Protioconazole [ppm]</td><td>Efficacy (%)</td>

<td colspan="3">Table 12</td>

<td>Compound carboxamide (5) [ppm]</td><td>Protioconazole [ppm]</td><td>Efficacy (%)</td>

<td colspan="3">Table 13</td>

<td>Compound carboxamide (1) [ppm]</td><td>Bromuconazole [ppm]</td><td>Efficacy (%)</td>

Table 14

<td colspan="2">Compound</td><td rowspan="2">Bromuconazole [ppm]</td><td rowspan="2">Efficacy (%)</td>

<td>carboxamide [ppm]</td><td> (5)</td>

Table 15

<td>Compound carboxamide (1) [ppm]</td><td>Tebuconazole [ppm]</td><td>Efficacy (%)</td>

Table 16

<td>Compound carboxamide (5) [ppm]</td><td>Tebuconazole [ppm]</td><td>Efficacy (%)</td>

Table 17

<td>Compound carboxamide (1) [ppm]</td><td>Epoxiconazole [ppm]</td><td>Efficacy (%)</td>

Table 18

<td colspan="2">Compound</td><td rowspan="2">Epoxiconazole [ppm]</td><td rowspan="2">Efficacy (%)</td>

<td>carboxamide [ppm]</td><td> (5)</td>

Table 19

<td>Compound carboxamide (1) [ppm]</td><td>Metconazole [ppm]</td><td>Efficacy (%)</td>

Table 20

<td>Compound carboxamide (5) [ppm]</td><td>Metconazole [ppm]</td><td>Efficacy (%)</td>

Table 21

<td>Compound carboxamide (1) [ppm]</td><td>Tetraconazole [ppm]</td><td>Efficacy (%)</td>

Table 22

<td>Compound carboxamide (5) [ppm]</td><td>Tetraconazole [ppm]</td><td>Efficacy (%)</td>

Industrial applicability

A pesticidal composition comprising a carboxamide compound represented by formula (I) and one or more azole compounds selected from group (A) is useful in controlling pests.

It is noted that in relation to this date, the best method known by the applicant to put the aforementioned invention into practice is the one that is clear from the present description of the invention.

Contents4

30 members in 20 offices

This recordMember, by publication datePriority claim10 more offices are in the list below

Priority claims2

Priority claims
Document	Office	Kind	Date
2010104093	Japan	A	2010-04-28
2011002416	Japan	W	2011-04-25

Members30

Family members, oldest first
Document	Office	Kind
CA2797376A1	Canada	A1	2011-11-03
WO2011135833A1	World Intellectual Property Organization (WIPO)	A1	2011-11-03
JP2011246452A	Japan	A	2011-12-08
AU2011246798A1	Australia	A1	2012-11-01
MX2012012303AThis record	Mexico	A	2012-11-23
CN102858172A	China	A	2013-01-02
AR083232A1	Argentina	A1	2013-02-13
EP2563135A1	European Patent Office (EPO)	A1	2013-03-06
US2013065854A1	United States of America	A1	2013-03-14
CL2012002973A1	Chile	A1	2013-03-22
KR20130066594A	Republic of Korea	A	2013-06-20
EP2563135A4	European Patent Office (EPO)	A4	2013-09-25
RU2012150804A	Russian Federation	A	2014-06-10
NZ603841A	New Zealand	A	2014-10-31
BR112012027386A2	Brazil	A2	2015-09-15
AU2011246798B2	Australia	B2	2015-09-17
UA109901C2	Ukraine	C2	2015-10-26
RU2569962C2	Russian Federation	C2	2015-12-10
MX337988B	Mexico	B	2016-03-30
US9375003B2	United States of America	B2	2016-06-28
EP2563135B1	European Patent Office (EPO)	B1	2016-09-14
DK2563135T3	Denmark	T3	2016-12-12
ES2605490T3	Spain	T3	2017-03-14
MY162552A	Malaysia	A	2017-06-15
PL2563135T3	Poland	T3	2017-06-30
HUE032449T2	Hungary	T2	2017-09-28
KR101849793B1	Republic of Korea	B1	2018-04-17
BR112012027386B1	Brazil	B1	2018-07-31
CA2797376C	Canada	C	2018-11-20
BR122017022817B1	Brazil	B1	2019-02-12

Plant disease control composition and its use.

Abstract

Term

COMPOSITION FOR THE CONTROL OF VEGETABLE DISEASES AND THEIR

USE

PTL 1: WO 86/02641

PTL 2: WO 92/12970

Priority claims2

Members30

Events

Numbers

Titles2

Classification